# Culp Inc: financial statements, quarterly CULP · Nasdaq · CIK 723603 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/culp.md) · [Financials](/companies/culp/financials.md) · [Filings](/companies/culp/filings.md) · [Insiders](/companies/culp/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/culp/financials.md?period=annual). ## Income statement | Line item | Unit | Q2 FY2024 (2023-10-29) | Q3 FY2024 (2024-01-28) | Q4 FY2024 (2024-04-28) | Q1 FY2025 (2024-07-28) | Q2 FY2025 (2024-10-27) | Q3 FY2025 (2025-01-26) | Q4 FY2025 (2025-04-27) | Q1 FY2026 (2025-08-03) | Q2 FY2026 (2025-11-02) | Q3 FY2026 (2026-02-01) | Q4 FY2026 (2026-05-03) | Q1 FY2027 (2026-08-02) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [58.7](/filings/0000950170-24-133885.md) | [60.4](/filings/0000950170-25-035191.md) | [49.5 d](/filings/0001193125-26-307064.md) | [56.5](/filings/0000723603-25-000004.md) | [55.7](/filings/0001193125-25-317167.md) | [52.3](/filings/0001193125-26-105579.md) | [48.8 d](/filings/0001193125-26-307064.md) | [50.7](/filings/0001193125-26-388759.md) | [53.2](/filings/0001193125-25-317167.md) | [48.0](/filings/0001193125-26-105579.md) | [51.6 d](/filings/0001193125-26-307064.md) | [54.0](/filings/0001193125-26-388759.md) | | Cost of revenue | $m | [50.8](/filings/0000950170-24-133885.md) | [52.7](/filings/0000950170-25-035191.md) | [44.3 d](/filings/0001193125-26-307064.md) | [51.5](/filings/0000723603-25-000004.md) | [49.7](/filings/0001193125-25-317167.md) | [45.9](/filings/0001193125-26-105579.md) | [41.1 d](/filings/0001193125-26-307064.md) | [43.5](/filings/0001193125-26-388759.md) | [47.4](/filings/0001193125-25-317167.md) | [42.6](/filings/0001193125-26-105579.md) | [44.8 d](/filings/0001193125-26-307064.md) | [38.6](/filings/0001193125-26-388759.md) | | Gross profit | $m | [8.0](/filings/0000950170-24-133885.md) | [7.7](/filings/0000950170-25-035191.md) | [5.2 d](/filings/0001193125-26-307064.md) | [5.1](/filings/0000723603-25-000004.md) | [6.0](/filings/0001193125-25-317167.md) | [6.3](/filings/0001193125-26-105579.md) | [7.7 d](/filings/0001193125-26-307064.md) | [7.2](/filings/0001193125-26-388759.md) | [5.8](/filings/0001193125-25-317167.md) | [5.3](/filings/0001193125-26-105579.md) | [6.8 d](/filings/0001193125-26-307064.md) | [15.4](/filings/0001193125-26-388759.md) | | Selling, general and administrative | $m | [10.0](/filings/0000950170-24-133885.md) | [9.5](/filings/0000950170-25-035191.md) | [9.2 d](/filings/0001193125-26-307064.md) | [9.3](/filings/0000723603-25-000004.md) | [9.4](/filings/0001193125-25-317167.md) | [8.6](/filings/0001193125-26-105579.md) | [8.5 d](/filings/0001193125-26-307064.md) | [9.1](/filings/0001193125-26-388759.md) | [8.7](/filings/0001193125-25-317167.md) | [8.5](/filings/0001193125-26-105579.md) | [8.3 d](/filings/0001193125-26-307064.md) | [8.7](/filings/0001193125-26-388759.md) | | Operating income | $m | [(2.2)](/filings/0000950170-24-133885.md) | [(1.7)](/filings/0000950170-25-035191.md) | [(4.2) d](/filings/0001193125-26-307064.md) | [(6.9)](/filings/0000723603-25-000004.md) | [(5.4)](/filings/0001193125-25-317167.md) | [(3.9)](/filings/0001193125-26-105579.md) | [(2.2) d](/filings/0001193125-26-307064.md) | [1.6](/filings/0001193125-26-388759.md) | [(3.5)](/filings/0001193125-25-317167.md) | [(3.7)](/filings/0001193125-26-105579.md) | [(1.6) d](/filings/0001193125-26-307064.md) | [6.7](/filings/0001193125-26-388759.md) | | Interest expense | $m | not reported | not reported | not reported | [0.0](/filings/0000723603-25-000004.md) | [0.0](/filings/0001193125-25-317167.md) | [0.1](/filings/0001193125-26-105579.md) | [0.1 d](/filings/0001193125-26-307064.md) | [0.2](/filings/0001193125-26-388759.md) | [0.2](/filings/0001193125-25-317167.md) | [0.2](/filings/0001193125-26-105579.md) | [0.2 d](/filings/0001193125-26-307064.md) | [0.2](/filings/0001193125-26-388759.md) | | Income tax | $m | [0.5](/filings/0000950170-24-133885.md) | [1.0](/filings/0000950170-25-035191.md) | [0.8 d](/filings/0001193125-26-307064.md) | [0.2](/filings/0000723603-25-000004.md) | [(0.1)](/filings/0001193125-25-317167.md) | [0.4](/filings/0001193125-26-105579.md) | [(0.2) d](/filings/0001193125-26-307064.md) | [1.4](/filings/0001193125-26-388759.md) | [0.2](/filings/0001193125-25-317167.md) | [0.3](/filings/0001193125-26-105579.md) | [0.1 d](/filings/0001193125-26-307064.md) | [0.9](/filings/0001193125-26-388759.md) | | Net income | $m | [(2.4)](/filings/0000950170-25-035191.md) | [(3.2)](/filings/0000950170-25-035191.md) | [(4.9) d](/filings/0001193125-26-307064.md) | [(7.3)](/filings/0001193125-26-105579.md) | [(5.6)](/filings/0001193125-26-105579.md) | [(4.1)](/filings/0001193125-26-105579.md) | [(2.1) d](/filings/0001193125-26-307064.md) | [(0.2)](/filings/0001193125-26-388759.md) | [(4.3)](/filings/0001193125-26-105579.md) | [(3.4)](/filings/0001193125-26-105579.md) | [(2.2) d](/filings/0001193125-26-307064.md) | [6.0](/filings/0001193125-26-388759.md) | | Diluted EPS | $ per share | [(0.19)](/filings/0000950170-24-133885.md) | [(0.26)](/filings/0000950170-25-035191.md) | not reported | [(0.58)](/filings/0000723603-25-000004.md) | [(0.45)](/filings/0001193125-25-317167.md) | [(0.33)](/filings/0001193125-26-105579.md) | not reported | [(0.02)](/filings/0001193125-26-388759.md) | [(0.34)](/filings/0001193125-25-317167.md) | [(0.27)](/filings/0001193125-26-105579.md) | not reported | [0.47](/filings/0001193125-26-388759.md) | | Basic EPS | $ per share | [(0.19)](/filings/0000950170-24-133885.md) | [(0.26)](/filings/0000950170-25-035191.md) | not reported | [(0.58)](/filings/0000723603-25-000004.md) | [(0.45)](/filings/0001193125-25-317167.md) | [(0.33)](/filings/0001193125-26-105579.md) | not reported | [(0.02)](/filings/0001193125-26-388759.md) | [(0.34)](/filings/0001193125-25-317167.md) | [(0.27)](/filings/0001193125-26-105579.md) | not reported | [0.47](/filings/0001193125-26-388759.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:ProfitLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q2 FY2024 (2023-10-29) | Q3 FY2024 (2024-01-28) | FY2024 (2024-04-28) | Q1 FY2025 (2024-07-28) | Q2 FY2025 (2024-10-27) | Q3 FY2025 (2025-01-26) | FY2025 (2025-04-27) | Q1 FY2026 (2025-08-03) | Q2 FY2026 (2025-11-02) | Q3 FY2026 (2026-02-01) | FY2026 (2026-05-03) | Q1 FY2027 (2026-08-02) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [15.2](/filings/0000950170-24-133885.md) | [12.6](/filings/0000950170-25-035191.md) | [10.0](/filings/0000950170-25-095233.md) | [13.5](/filings/0000723603-25-000004.md) | [10.5](/filings/0001193125-25-317167.md) | [5.3](/filings/0001193125-26-105579.md) | [5.6](/filings/0001193125-26-307064.md) | [11.1](/filings/0001193125-26-388759.md) | [10.7](/filings/0001193125-25-317167.md) | [9.7](/filings/0001193125-26-105579.md) | [8.3](/filings/0001193125-26-388759.md) | [10.2](/filings/0001193125-26-388759.md) | | Current assets | $m | [88.6](/filings/0000950170-24-133885.md) | [89.1](/filings/0000950170-25-035191.md) | [80.9](/filings/0000950170-25-095233.md) | [82.7](/filings/0000723603-25-000004.md) | [86.9](/filings/0001193125-25-317167.md) | [85.3](/filings/0001193125-26-105579.md) | [83.5](/filings/0001193125-26-307064.md) | [88.9](/filings/0001193125-26-388759.md) | [90.4](/filings/0001193125-25-317167.md) | [88.4](/filings/0001193125-26-105579.md) | [80.7](/filings/0001193125-26-388759.md) | [78.8](/filings/0001193125-26-388759.md) | | Total assets | $m | [142](/filings/0000950170-24-133885.md) | [142](/filings/0000950170-25-035191.md) | [132](/filings/0000950170-25-095233.md) | [129](/filings/0000723603-25-000004.md) | [129](/filings/0001193125-25-317167.md) | [128](/filings/0001193125-26-105579.md) | [123](/filings/0001193125-26-307064.md) | [126](/filings/0001193125-26-388759.md) | [125](/filings/0001193125-25-317167.md) | [121](/filings/0001193125-26-105579.md) | [112](/filings/0001193125-26-388759.md) | [108](/filings/0001193125-26-388759.md) | | Current liabilities | $m | [41.6](/filings/0000950170-24-133885.md) | [43.4](/filings/0000950170-25-035191.md) | [38.1](/filings/0000950170-25-095233.md) | [42.2](/filings/0000723603-25-000004.md) | [48.4](/filings/0001193125-25-317167.md) | [50.6](/filings/0001193125-26-105579.md) | [47.0](/filings/0001193125-26-307064.md) | [47.9](/filings/0001193125-26-388759.md) | [51.3](/filings/0001193125-25-317167.md) | [51.6](/filings/0001193125-26-105579.md) | [45.0](/filings/0001193125-26-388759.md) | [43.5](/filings/0001193125-26-388759.md) | | Total liabilities | $m | [58.5](/filings/0000950170-24-133885.md) | [61.2](/filings/0000950170-25-035191.md) | [55.9](/filings/0000950170-25-095233.md) | [60.0](/filings/0000723603-25-000004.md) | [65.4](/filings/0001193125-25-317167.md) | [67.9](/filings/0001193125-26-105579.md) | [65.7](/filings/0001193125-26-307064.md) | [68.8](/filings/0001193125-26-388759.md) | [71.7](/filings/0001193125-25-317167.md) | [70.5](/filings/0001193125-26-105579.md) | [63.8](/filings/0001193125-26-388759.md) | [54.3](/filings/0001193125-26-388759.md) | | Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [83.6](/filings/0000950170-25-035191.md) | [80.8](/filings/0000950170-25-035191.md) | [76.1](/filings/0001193125-26-307064.md) | [69.1](/filings/0001193125-26-105579.md) | [63.6](/filings/0001193125-26-105579.md) | [59.7](/filings/0001193125-26-105579.md) | [57.6](/filings/0001193125-26-388759.md) | [57.6](/filings/0001193125-26-388759.md) | [53.6](/filings/0001193125-26-105579.md) | [50.2](/filings/0001193125-26-105579.md) | [48.1](/filings/0001193125-26-388759.md) | [54.2](/filings/0001193125-26-388759.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: not reported - Current portion of debt: not reported - Short-term borrowings: not reported - Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest ## Cash flow | Line item | Unit | Q2 FY2024 (2023-10-29) | Q3 FY2024 (2024-01-28) | Q4 FY2024 (2024-04-28) | Q1 FY2025 (2024-07-28) | Q2 FY2025 (2024-10-27) | Q3 FY2025 (2025-01-26) | Q4 FY2025 (2025-04-27) | Q1 FY2026 (2025-08-03) | Q2 FY2026 (2025-11-02) | Q3 FY2026 (2026-02-01) | Q4 FY2026 (2026-05-03) | Q1 FY2027 (2026-08-02) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $k | [(41.0) d](/filings/0000950170-24-133885.md) | [(1,494) d](/filings/0000950170-25-035191.md) | [(2,254) d](/filings/0001193125-26-307064.md) | [(206)](/filings/0000723603-25-000004.md) | [(2,427) d](/filings/0001193125-25-317167.md) | [(6,792) d](/filings/0001193125-26-105579.md) | [(8,225) d](/filings/0001193125-26-307064.md) | [(695)](/filings/0001193125-26-388759.md) | [(471) d](/filings/0001193125-25-317167.md) | [(1,101) d](/filings/0001193125-26-105579.md) | [(7,104) d](/filings/0001193125-26-307064.md) | [8,102](/filings/0001193125-26-388759.md) | | Capital expenditure | $k | [1,459 d](/filings/0000950170-24-133885.md) | [1,277 d](/filings/0000950170-25-035191.md) | [462 d](/filings/0001193125-26-307064.md) | [501](/filings/0000723603-25-000004.md) | [1,077 d](/filings/0001193125-25-317167.md) | [862 d](/filings/0001193125-26-105579.md) | [507 d](/filings/0001193125-26-307064.md) | [179](/filings/0001193125-26-388759.md) | [39.0 d](/filings/0001193125-25-317167.md) | [224 d](/filings/0001193125-26-105579.md) | [154 d](/filings/0001193125-26-307064.md) | [314](/filings/0001193125-26-388759.md) | | Dividends paid | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets - Dividends paid: not reported - Share repurchases: not reported ## Shares | Line item | Unit | Q2 FY2023 (2022-10-30) | Q3 FY2023 (2023-01-29) | Q1 FY2024 (2023-07-30) | Q2 FY2024 (2023-10-29) | Q3 FY2024 (2024-01-28) | Q1 FY2025 (2024-07-28) | Q2 FY2025 (2024-10-27) | Q3 FY2025 (2025-01-26) | Q1 FY2026 (2025-08-03) | Q2 FY2026 (2025-11-02) | Q3 FY2026 (2026-02-01) | Q1 FY2027 (2026-08-02) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [12.3](/filings/0000950170-23-068943.md) | [12.3](/filings/0000950170-24-028377.md) | [12.3](/filings/0000950170-24-104243.md) | [12.5](/filings/0000950170-24-133885.md) | [12.5](/filings/0000950170-25-035191.md) | [12.5](/filings/0000723603-25-000004.md) | [12.5](/filings/0001193125-25-317167.md) | [12.6](/filings/0001193125-26-105579.md) | [12.6](/filings/0001193125-26-388759.md) | [12.6](/filings/0001193125-25-317167.md) | [12.7](/filings/0001193125-26-105579.md) | [12.8](/filings/0001193125-26-388759.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 12,735,324 at 2026-09-09, from the cover of the [10-Q filed 2026-09-11](/filings/0001193125-26-388759.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.